Table 2 Concomitant, biological and medication related factors of the study participants, University of Gondar, 2016
| Â | Â | Total | Tb treatment outcome, n (%) | |
|---|---|---|---|---|
Variables/factors | Categories | N = 308 | Successful | Unsuccessful |
CD4+ count at TB treatment entry | <200 cells/mm2 | 195 | 149(76.4) | 46(23.6) |
≥200 cells/mm2 | 113 | 89(78.8) | 24(21.2) | |
Mean base line weight (kg) at TB treatment entry | <43.7 | 132 | 92(69.7) | 40(30.3) |
≥43.7 | 176 | 146(83.0) | 30(17.0) | |
Functional status | Working | 163 | 136(83.4) | 27(16.7) |
Ambulatory | 88 | 74(84.1) | 14(15.9) | |
Bedridden | 57 | 28(49.1) | 29(50.9) | |
INH prophylaxis | Yes | 12 | 10(83.3) | 2(16.7) |
no | 296 | 228(77.0) | 68(23.0) | |
CPT | Yes | 274 | 214(78.1) | 60(21.9) |
no | 34 | 24(70.6) | 10(29.4) | |
ART at TB treatment entry | pre-ART | 188 | 143(76.1) | 45(23.9) |
on ART | 120 | 95(79.2) | 25(20.8) | |
WHO staging | III | 188 | 154(81.9) | 34(18.1) |
IV | 120 | 84(70.0) | 36(30.0) | |
TB treatment history | Yes | 77 | 59(76.6) | 18(23.4) |
No | 231 | 179(77.5) | 52(22.5) | |
TB type | Pulmonary | 219 | 175(79.9) | 44(20.1) |
Extra-pulmonary TB | 89 | 63(78.8) | 26(29.2) | |
Category(case definition) of TB | New TB cases | 221 | 169(76.5) | 52(23.5) |
Relapse cases | 48 | 37(77.1) | 11(22.9) | |
Transfer in | 39 | 32(82.1) | 7(17.9) | |
Smear status (n = 219) | Positive | 47 | 38(80.9) | 9(19.1) |
Negative | 172 | 133(77.3) | 39(22.7) | |
Treatment side effect | Yes | 18 | 10(55.6) | 8(44.4) |
No | 290 | 228(78.6) | 62(21.4) | |